A late-stage trial of dupilumab in young children showed the biologic induced remission in eosinophilic esophagitis (EoE). Sanofi and Regeneron Thursday announced positive results from a pivotal phase ...
Among patients with eosinophilic esophagitis (EoE), both those who are responsive to proton pump inhibitors (PPIs) and those who are unresponsive to PPI treatment share similar esophageal protein ...
A recent review points to a host of potentially disease-modifying agents currently in clinical trials. Eosinophilic esophagitis (EoE), a chronic immune condition affecting the gastrointestinal system, ...
Please provide your email address to receive an email when new articles are posted on . Children with eosinophilic esophagitis currently rely on elimination diets. The safety profile for this age ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Cendakimab sustained improvements in symptoms and ...
Eosinophilic esophagitis (EoE) is a chronic (long-term) condition affecting the esophagus, the tube that carries food and liquids from the mouth to the stomach. EoE causes symptoms like difficulty ...
NEW ORLEANS, La. (Ivanhoe Newswire)-- We’ve all seen them and some of us have one at home: picky eaters. A toddler that just won’t eat, no matter what you put on their plate. Well, it may be just a ...
We’ve all seen them and some of us even have one at home: picky eaters. A toddler that just won’t eat, no matter what you put on their plate, may be just a phase, but experts say it could be an ...
Ready to experience “The End of Evangelion” on the big screen? GKIDS, the producer and distributor of some of the very best animated features from around the world announced that it will bring “The ...
One of the greatest anime series of a generation had its ending revised by a fan-favorite feature film, and it was absolutely ...
FLORHAM PARK, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...